Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Local drug delivery and gene therapy]

H Darius1, M Buerke, J P Boissel

  • 1II. Medizinische Klinik, Johannes Gutenberg-Universität, Mainz. darius@2-med.klinik.uni-mainz.de

Herz
|March 4, 1998
PubMed
Summary

Local drug and gene delivery strategies show promise for preventing restenosis after coronary angioplasty. While animal studies are encouraging, clinical evidence for gene therapy in vascular diseases remains limited.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Antithrombotic treatment in acute coronary syndrome and atrial fibrillation].

Herz·2019
Same author

The German CPU registry: Comparison of smokers and nonsmokers.

Herz·2018
Same author

[Hemorrhage under direct oral anticoagulants : Occurrence and treatment in intensive care patients].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2018
Same author

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?

Clinical research in cardiology : official journal of the German Cardiac Society·2018
Same author

[NOAC: Real-life data and the role of antidotes for the treatment of bleeding].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same author

[Bleeding in patients receiving dual antiplatelet therapy after acute coronary syndrome - significance, prevention and interdisciplinary management].

Deutsche medizinische Wochenschrift (1946)·2016

Area of Science:

  • Cardiovascular Medicine
  • Molecular Cardiology
  • Biotechnology

Context:

  • Restenosis following coronary balloon angioplasty remains a significant clinical challenge.
  • Current systemic drug therapies have largely failed to prevent neointima formation.
  • Understanding the pathophysiology of neointima formation is incomplete.

Purpose:

  • To explore innovative strategies for preventing restenosis, focusing on local drug and gene delivery.
  • To review advancements in catheter devices and drug delivery systems for localized treatment.
  • To assess the potential of gene therapy in inhibiting vascular smooth muscle cell proliferation.

Summary:

  • Local administration of high-dose drugs and gene-based interventions are promising approaches to inhibit neointima formation.

Related Experiment Videos

  • Catheter devices facilitate targeted delivery of drugs or DNA directly into coronary arteries.
  • Animal models show efficacy of antisense oligonucleotides and cDNA transfer; however, clinical data is scarce.

    • Impact:

    • Local delivery systems and gene therapy offer potential for improved restenosis treatment.
    • Further clinical validation is required to integrate gene transfer techniques into standard vascular disease care.
    • This research highlights the need for continued investigation into localized therapeutic strategies.